Page breadcrumb nav

VAERS Report 2156808

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Male

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-15
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

shortness of breath; headache; sore throat; leg cramps; tiredness; eye pain; low mood; appetite lost; this is a spontaneous report received from a contactable reporter (consumer) from the regulatory auhtority. regulatory number: gb-mhra-webcovid-202202171626168250-nkabj. other case identifier: gb-mhra-adr 26614034. a 28-year-old male patient received bnt162b2 (comirnaty), administration date 15feb2022 (lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. vaccination history included: bnt162b2 (as dose 1, single), for covid-19 immunisation and bnt162b2 (as dose 2, single), for covid-19 immunisation. the following information was reported: dyspnoea (medically significant) with onset feb2022, outcome "recovering", described as "shortness of breath"; headache (medically significant) with onset feb2022, outcome "recovering", described as "headache"; oropharyngeal pain (medically significant) with onset feb2022, outcome "recovering", described as "sore throat"; muscle spasms (medically significant) with onset feb2022, outcome "recovered" (feb2022), described as "leg cramps"; fatigue (medically significant) with onset feb2022, outcome "recovering", described as "tiredness"; eye pain (medically significant) with onset feb2022, outcome "recovered" (feb2022), described as "eye pain"; depressed mood (medically significant) with onset feb2022, outcome "recovering", described as "low mood"; and decreased appetite (medically significant) with onset feb2022, outcome "recovering", described as "appetite lost." clinical course: patient has not had symptoms associated with covid-19 and has not had a covid-19 test. he is not enrolled in a clinical trial. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Données de laboratoire
na
Liste des symptômes
fatigue headache decreased appetite muscle spasms eye pain dyspnoea oropharyngeal pain depressed mood
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na